MED1 Ablation Promotes Oral Mucosal Wound Healing via JNK Signaling Pathway. 2022

Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
School of Stomatology, Tianjin Medical University, Tianjin 300014, China.

Mediator complex subunit 1 (MED1) is a coactivator of multiple transcription factors and plays a key role in regulating epidermal homeostasis as well as skin wound healing. It is unknown, however, whether it plays a role in healing oral mucosal wounds. In this study, we investigate MED1's functional effects on oral mucosal wound healing and its underlying mechanism. The epithelial-specific MED1 null (Med1epi-/-) mice were established using the Cre-loxP system with C57/BL6 background. A 3 mm diameter wound was made in the cheek mucosa of the 8-week-old mice. In vivo experiments were conducted using HE staining and immunostaining with Ki67 and uPAR antibodies. The in vitro study used lentiviral transduction, scratch assays, qRT-PCR, and Western blotting to reveal the underlying mechanisms. The results showed that ablation of MED1 accelerated oral mucosal wound healing in 8-week-old mice. As a result of ablation of MED1, Activin A/Follistatin expression was altered, resulting in an activation of the JNK/c-Jun pathway. Similarly, knockdown of MED1 enhanced the proliferation and migration of keratinocytes in vitro, promoting re-epithelialization, which accelerates the healing of oral mucosal wounds. Our study reveals a novel role for MED1 in oral keratinocytes, providing a new molecular therapeutic target for accelerated wound healing.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004817 Epidermis The external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: (1) basal layer (stratum basale epidermidis); (2) spinous layer (stratum spinosum epidermidis); (3) granular layer (stratum granulosum epidermidis); (4) clear layer (stratum lucidum epidermidis); and (5) horny layer (stratum corneum epidermidis).
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056913 Mediator Complex Subunit 1 A mediator complex subunit that is believed to play a key role in the coactivation of nuclear receptor-activated transcription by the mediator complex. It interacts with a variety of nuclear receptors including RETINOIC ACID RECEPTORS; THYROID HORMONE RECEPTORS; VITAMIN D RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; ESTROGEN RECEPTORS; and GLUCOCORTICOID RECEPTORS. DRIP205,Mediator of RNA Polymerase II Transcription Subunit 1,PPAR-Binding Protein,Peroxisome Proliferator-Activated Receptor Binding Protein,RB18A,TR-Associated Protein P220,TRAP220,TRIP2 (Thyroid Receptor Interacting Protein 2),Thyroid Hormone Receptor Associated Protein 220,Thyroid Receptor Interacting Protein 2,Vitamin D Receptor-Interacting Protein Complex Component DRIP205,p53 Regulatory Protein RB18A,PPAR Binding Protein,Peroxisome Proliferator Activated Receptor Binding Protein,TR Associated Protein P220,Vitamin D Receptor Interacting Protein Complex Component DRIP205
D062326 Re-Epithelialization Reconstitution of eroded or injured EPITHELIUM by proliferation and migration of EPITHELIAL CELLS from below or adjacent to the damaged site. Wound Epithelialization,Epithelialization, Wound,Re Epithelialization
D020935 MAP Kinase Signaling System An intracellular signaling system involving the mitogen-activated protein kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade. MAP Kinase Cascade,MAP Kinase Module,MAP Kinase Signaling Cascade,MAP Kinase Signaling Pathway,MAP Kinase Signaling Pathways,ERK Pathway,ERK Signal Tranduction Pathway,ERK1 and ERK2 Pathway,ERK1-2 Pathway,JNK Pathway,JNK Signaling Pathway,MAP Kinase Modules,MAP Kinase Signaling Cascades,MEK-ERK Pathway,p38 Kinase Pathway,p38 Kinase Signaling Pathway,Cascade, MAP Kinase,ERK Pathways,ERK1 2 Pathway,ERK1-2 Pathways,JNK Pathways,JNK Signaling Pathways,Kinase Cascade, MAP,Kinase Pathway, p38,Kinase Pathways, p38,MAP Kinase Cascades,MEK ERK Pathway,MEK-ERK Pathways,Module, MAP Kinase,Pathway, ERK,Pathway, ERK1-2,Pathway, JNK,Pathway, JNK Signaling,Pathway, MEK-ERK,Pathway, p38 Kinase,Pathways, ERK,Pathways, ERK1-2,Pathways, JNK,Pathways, JNK Signaling,Pathways, MEK-ERK,Pathways, p38 Kinase,Signaling Pathway, JNK,Signaling Pathways, JNK,p38 Kinase Pathways

Related Publications

Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
April 2024, Experimental eye research,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
January 2011, PloS one,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
September 2014, Cell transplantation,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
February 2024, Archives of oral biology,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
January 2002, Developmental biology,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
January 2019, Frontiers in pharmacology,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
January 2021, Journal of dental sciences,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
May 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
April 2005, Developmental biology,
Zhaosong Meng, and Zhe Li, and Shuling Guo, and Danfeng Wu, and Ran Wei, and Jiacheng Liu, and Lizhi Hu, and Lei Sui
April 2019, Diabetes research and clinical practice,
Copied contents to your clipboard!